Also on this list

SnagRx
$69 semaglutide and $119 tirzepatide "locked in for life," but every payment is final.
On our semaglutide provider ranking. Noom Med is reviewed here but not listed there.
Read the SnagRx review →Provider review
Its microdose page says "up to 17 pounds in 60 days"; its footnote's average is 5.8.
The microdose plan costs $79 for the first four weeks of medication, then $179 a month plus tax on a 12-week subscription. No pharmacy is named, and clinicians come from outside partners.
By Marcus Webb
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. A commission does not change what a review says. Full disclosure here.
At a glance
Visit Noom MedPharmacy
Not categorized
Labs
Some plans include lab tests in the subscription price,…
States
Not stated
Also on this list

SnagRx
$69 semaglutide and $119 tirzepatide "locked in for life," but every payment is final.
On our semaglutide provider ranking. Noom Med is reviewed here but not listed there.
Read the SnagRx review →What this price covers
Medication
Included
Provider visits
Included
Shipping
Not confirmed
Lab work
Not confirmed
Coaching
Not confirmed
The catch — The $79 covers three weeks of program and four weeks of medication; after that the plan renews on a 12-week subscription at $179 a month plus tax. "Final pricing depends on program selection," the $179 applies to new accounts from July 27, 2026, and its own blog still advertises $199.
See plans at Noom MedPrices read from Noom Med's own site
What they advertise
"Limited Time Offer: Plans start at $79" for the microdose plan. The Noom Med page lists "GLP-1s starting at $79, regardless of insurance" and Ozempic and Zepbound "starting at $39 plus any out-of-pocket cost for the medication itself."
What you actually pay
$179 a month plus tax for the microdose plan after the first period, medication included: "Initial 3 week subscription and 4 weeks of medication from $79 plus tax and $179 per month plus tax for 12 week subscription thereafter." No price is printed for the standard compounded plan, and brand-name drugs are paid on top of the program fee.
Money you will meet later
Noom Med is the prescription program of Noom, Inc., the weight-loss app company. Through outside clinical partners it prescribes brand-name GLP-1s (Wegovy, the Wegovy pill, Ozempic, Zepbound, Mounjaro, Foundayo), generic liraglutide and metformin, and its own Noom GLP-1Rx programs of compounded semaglutide and tirzepatide, including a low-dose microdose plan. Every plan comes with the Noom app, a coach and its GLP-1 Companion lessons. Only the microdose plan has a current price: $79 for an initial three weeks with four weeks of medication, then $179 a month plus tax on a 12-week subscription. Its blog still prints older figures, $199 a month for that plan and $299 for its standard program, and brand-name plans start at $39 plus the drug. The results claims need the most care: the microdose page promises "up to 17 pounds in 60 days" while its own footnote puts the average at 5.8 pounds. No pharmacy is named, and fees are generally non-refundable.
Noom Med is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking.
Noom Med states no 503A/503B category for the pharmacy that fills your prescription.
Not named. It says it partners with "USP-compliant, state-regulated pharmacies" that buy ingredients from FDA-registered facilities, with each batch third-party tested and a certificate of analysis available from its care team on request. Its Terms say compounded prescriptions can only be filled by a pharmacy partner on its platform; brand-name prescriptions can go to your own pharmacy.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Not published. Its microdose page says "Not available in all 50 states" without naming them.
The part they would rather you skipped
Noom's microdose page promises members "lose up to 17 pounds in 60 days." Its own footnote describes the study behind that number, "3,562 Noom users self-reported data," and gives the "Average expected weight loss for those who followed the titration protocol" as 5.8 pounds. Its GLP-1 access page puts the same 60-day figure at 11 pounds, for members in the top quarter. The Noom Med page does the same with its main benefit: "Lose 37% more weight with Noom Med than medication alone" at the top, "48% more weight in 6 months" in its FAQ, with the 48% footnoted to clinical trials of branded Wegovy and Zepbound rather than to Noom data. The prices need the same care. The microdose page charges $179 a month to new accounts from July 27, 2026, and Noom's own blog still advertises $199.
Other providers on our semaglutide provider ranking. Noom Med is reviewed here but not listed there.






181 more providers are on our semaglutide provider ranking — see the full list. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check Noom Med's current pricing before you decide. Ours was read from their own site.
Facts on this page reflect Noom Med's own public disclosures when we last checked them. Prices and terms change without notice — confirm on Noom Med's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
Noom Med
See current pricing